Wai Conrad
- SEC CIK
- 0001971702
In the past year, 3 open-market sale filings worth $2.41M and no purchases.
Current role at each company
- CLOV Clover Health Investments, Corp.CEO, Counterpart Healthas of Sep 16, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.41M
- 3 filings
- Net
- −$2.41M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wai Conrad as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 (view filing)4:27 PM ET | Sep 15 | 1 day | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −300.0K | $4.72 | −$1.42M | −20.4%1.17M after | 10b5-1 |
| Jul 16, 2026 (view filing)4:55 PM ET | Jul 15 | 1 day | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −24.2K | $4.67 | −$113.1K | −2.1%1.15M after | 10b5-1 |
| May 28, 2026 (view filing) | May 28 | Same day | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −220.4K | $3.99 | −$879.5K | −13.7%1.39M after | 10b5-1 |
| Jul 24, 2025 (view filing) | Jul 22-23 | 2 days | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −209.8K | $3.30 | −$693.0K | −13.0%1.40M after | 2 lots10b5-1 |
| Jul 10, 2025 (view filing) | Jul 8 | 2 days | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −15.2K | $3.26 | −$49.6K | −0.9%1.61M after | Amended10b5-1 |